Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture Apalutamide Tablets, 60 mg.

Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last ...

Zydus Hospital has introduced Next-Generation Sequencing (NGS), a molecular tool for detecting genetic mutations linked to ...

Recalling the horror, which unfolded before his eyes, Shah said that the driver of the car did not stop after hitting the ...

A group of youths, including the son of a local bootlegger, had put an open challenge to Surat police to identify them ...

India still relies largely on imported devices and implants, when it comes to MedTech. This offers us a great opportunity to ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

Zydus will focus on state-of-the-art manufacturing capabilities that will enable high quality solutions for patients with cutting-edge research and innovation, reports Financial Express.

The Dasatinib tablets—which are used for treating chronic myeloid leukaemia in newly diagnosed adults—will be manufactured at Zydus Lifesciences' unit in its special economic zone located in Ahmedabad ...